Tag

Peptides

All articles tagged with #peptides

MIT Study Shows Peptides Can Survive in Venus’s 98% Sulfuric Acid Clouds
space-and-spaceflight11 days ago

MIT Study Shows Peptides Can Survive in Venus’s 98% Sulfuric Acid Clouds

Researchers at MIT have demonstrated that complex biological signaling molecules, specifically peptides, can maintain stable three-dimensional structures in environments mimicking Venus’s upper atmosphere. By testing three specific peptides in 98% sulfuric acid, the team found they remained intact for weeks, suggesting that Venus’s cloud layers may be chemically hospitable to certain forms of complex biochemistry despite their extreme acidity.

DIY peptides lure menopausal women into an unregulated treatment path
health17 days ago

DIY peptides lure menopausal women into an unregulated treatment path

A growing number of menopausal women are turning to online-sold experimental peptides marketed as ‘research use only,’ often without medical oversight. Some report relief from symptoms like hot flashes, pain, and fatigue, but experts warn of scams, dosing mistakes, dangerous reactions, and mislabeled products, highlighting a widening gap between promising anecdotes and FDA-approved therapies.

DIY Peptides: Women Push Boundaries in a High-Risk Wellness Trend
health17 days ago

DIY Peptides: Women Push Boundaries in a High-Risk Wellness Trend

A feature on the surge of do-it-yourself peptide use, especially among women, spurred by social media and gray-market suppliers. People buy pills, nasal sprays, or injectables for pain relief, hormonal issues, and fertility support, often via compounding pharmacies or online vendors; while peptides promise benefits, there is little rigorous human data and real safety risks—including infections and adverse reactions—leading experts to call for oversight, a registry, and more trials as some markets push for FDA changes.

Teens chase cosmetic perfection with unproven peptide injections guided by social media
lifestyle1 month ago

Teens chase cosmetic perfection with unproven peptide injections guided by social media

A Yahoo Life investigation shows American teenagers increasingly turning to unapproved peptide injections to alter their appearance, prompted by looksmaxxing influencers and social media. Teens can order lab-made peptides like MT-2, GH-KCU, IGF-1, and CMAX for at-home use, despite these substances lacking FDA approval and being intended for research only. The piece follows a 16-year-old peer,

Collagen-Boosting Skincare: 11 Ingredients Dermatologists Recommend
beauty1 month ago

Collagen-Boosting Skincare: 11 Ingredients Dermatologists Recommend

Vogue’s beauty guide lists 11 skin-care ingredients that help protect or boost collagen as production naturally declines with age: retinoids (with sun-sensitivity considerations), vitamin C as a collagen-synthesis cofactor, copper peptides for repair, niacinamide for barrier support, growth factors to signal renewal, plus hyaluronic acid, ceramides, sunscreen, AHAs, bakuchiol (retinol alternative), and PDRN. Each ingredient supports collagen through various mechanisms—synthesis, barrier health, hydration, and repair—while editors caution against over-exfoliation and irritation and recommend introducing actives gradually and pairing retinoids with hydrating ingredients.

Sunshine State's peptide boom: promises, perils, and regulatory gaps
health1 month ago

Sunshine State's peptide boom: promises, perils, and regulatory gaps

Florida is seeing a surge in injections of unapproved, often online-sold peptides promoted by clinics and social media influencers. While some advocates claim benefits for recovery, sleep, fat loss and anti-aging, most peptides lack robust safety data and proven efficacy. Experts warn about quality control issues, impurities, immune reactions, and potential cancer risk, plus a lack of standardized dosing. Regulators are considering tighter access through compounding pharmacies, but costs vary widely—from around $30 for raw powders to $1,500+ per month for clinic programs—and insurance rarely covers them. The trend highlights ongoing tensions between hype, science, and patient safety.

FDA may expand access to unapproved peptides, but safety remains unsettled
health1 month ago

FDA may expand access to unapproved peptides, but safety remains unsettled

A FDA advisory panel voted to increase access to six unapproved peptides via compounding pharmacies with prescriptions, potentially changing peptide regulation. Experts caution that being more accessible does not mean these peptides are proven safe or effective—many remain untested and unregulated—though compounding could improve purity. The panel's recommendation is not final, and formal rulemaking is required; consumers should weigh potential benefits against significant safety uncertainties.

Regulatory Clash as Online Peptide Craze Outpaces Science
sciencehealth-policy2 months ago

Regulatory Clash as Online Peptide Craze Outpaces Science

The online hype around MOTS-c and other peptides has spawned unregulated use with little human safety data; researchers press for quality-controlled, prescriber-supervised compounding as a safer alternative to the black market, while FDA staff warn against it due to safety gaps; an FDA panel narrowly backed allowing six peptides to be manufactured via compounding—sparking a policy fight over access, safety, and the future of peptide therapies.

FDA Panel Backs Six Peptides for Compounding, But Legal Access Hangs on Rulemaking
health-policy2 months ago

FDA Panel Backs Six Peptides for Compounding, But Legal Access Hangs on Rulemaking

An FDA Pharmacy Compounding Advisory Committee narrowly recommended six of seven peptides for inclusion on the 503A Bulks List—BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon—with emideltide rejected. The vote advances a nonbinding advisory step, but none of the substances is FDA-approved and final access hinges on proposed and final rulemaking. Available studies are short and small, leaving safety and efficacy data weak. The panel's reconstitution drew scrutiny over conflicts of interest, and payers should expect continued out-of-pocket use and online sourcing, with emphasis on careful medication reconciliation and safety monitoring until more data are available.

FDA panel backs broader access to six peptides through compounding pharmacies
health2 months ago

FDA panel backs broader access to six peptides through compounding pharmacies

An FDA advisory committee voted to recommend expanding access to six peptides (BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon) by adding them to the 503A Bulks List, potentially enabling licensed pharmacies to prepare prescriptions instead of relying on unregulated online sources. The vote covers six of seven peptides reviewed; the FDA must still issue a final decision. While supporters view it as progress toward safer access, experts caution that safety and efficacy data vary across peptides and emphasize requiring qualified clinicians, licensed pharmacies, quality testing, and patient monitoring—without treating this as blanket approval.

FDA Panel Bets Big on Six Peptides Amid Safety Debates
health2 months ago

FDA Panel Bets Big on Six Peptides Amid Safety Debates

An FDA advisory panel voted to recommend approving six of seven peptides previously banned, including BPC-157, TB-500, KPV, MOTS-c, Emideltide, and Semax (Epitalon was rejected), signaling a potential surge in a U.S. peptide industry but drawing scrutiny over safety data and whether it will curb the gray market; final agency approval remains uncertain and could stretch into 2027.

PDRN Skincare: The Salmon-Derived Ingredient Filling Wrinkles
beauty2 months ago

PDRN Skincare: The Salmon-Derived Ingredient Filling Wrinkles

A HuffPost Shopping piece explains polydeoxyribonucleotide (PDRN), a salmon-sperm–derived DNA ingredient touted to boost collagen and hydration to reduce wrinkles. It profiles popular Korean PDRN products—from Iope’s PDRN Caffeine Shot serum to Medicube’s five-peptide formulas and VT Cosmetics’ PDRN 100 Essence—along with Rejuran Turnover ampoule and other novel formulations, while noting plant-based vegan PDRN options and the experts’ caveats about endorsements.

FDA Panel Clears 6 of 7 Banned Peptides for Compounding, Sparking Safety Debate
health2 months ago

FDA Panel Clears 6 of 7 Banned Peptides for Compounding, Sparking Safety Debate

An FDA Pharmacy Compounding Advisory Committee voted to remove six peptides from the Category 2 ban list (BPC-157, KPV, TB-500, MOTs-C, epitalon, semax) while keeping emideltide restricted, signaling broader access to unapproved peptides via compounding despite limited safety and efficacy data; the non-binding recommendations come amid RFK Jr.’s push to expand peptide use, raising questions about real-world safety and effectiveness.

Peptides win FDA panel ok, CRISPR tragedy raises ethics questions, insulin supply tightens biotech spotlight
biotech2 months ago

Peptides win FDA panel ok, CRISPR tragedy raises ethics questions, insulin supply tightens biotech spotlight

An FDA panel narrowly approved allowing compounding pharmacies to produce certain unregulated peptides—a win for RFK Jr.—while Science reports a six-year-old girl's death in China after an experimental brain-directed CRISPR therapy, prompting ethics and oversight concerns; Sanofi insulin pens are in short supply, underscoring ongoing biotech and pharmaceutical tensions.